The role of beta-blockers in the treatment of chronic heart failure

Trends in Pharmacological Sciences

Volumn 32, Issue 4, 2011, Pages 206-212

  Kubon, Christer ^a   Mistry, Nisha B ^a   Grundvold, Irene ^a   Halvorsen, Sigrun ^a   Kjeldsen, Sverre E ^a   Westheim, Arne S ^a  

^a UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; BUCINDOLOL; CARVEDILOL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENALAPRIL; IVABRADINE; METOPROLOL; METOPROLOL SUCCINATE; METOPROLOL TARTRATE; NEBIVOLOL; PLACEBO; PROPRANOLOL; TIMOLOL;

ANTIOXIDANT ACTIVITY; CLINICAL TRIAL (TOPIC); CONGESTIVE CARDIOMYOPATHY; DISEASE SEVERITY; DRUG DOSE TITRATION; DRUG EFFICACY; ELDERLY CARE; HEART FAILURE; HEART INFARCTION; HEART RATE; HUMAN; MORBIDITY; MORTALITY; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; SURVIVAL; SYSTOLIC DYSFUNCTION;

ADRENERGIC BETA-ANTAGONISTS; CHRONIC DISEASE; DRUG DELIVERY SYSTEMS; HEART FAILURE; HEART RATE; HUMANS; SYSTOLE; VENTRICULAR FUNCTION, LEFT;

EID: 79954419785     PISSN: 01656147     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tips.2011.01.006     Document Type: Review

References (48)

1. Sir James Black, OM, Telegraph.co.uk; 23 Mar 2010
2. E.M. Gilbert Comparative hemodynamic, left ventricular functional, and antiadrenergic effects of chronic treatment with metoprolol versus carvedilol in the failing heart Circulation 94 1996 2817 2825 (Pubitemid 26411746)
3. S.D. Prabhu Beta-adrenergic blockade in developing heart failure: effects on myocardial inflammatory cytokines, nitric oxide, and remodeling Circulation 101 2000 2103 2109 (Pubitemid 30233176)
4. B.A. Groenning Antiremodeling effects on the left ventricle during beta-blockade with metoprolol in the treatment of chronic heart failure J. Am. Coll. Cardiol. 36 2000 2072 2080
5. N.G. Bellenger Effects of carvedilol on left ventricular remodeling in chronic stable heart failure: a cardiovascular magnetic resonance study Heart 90 2004 760 764 (Pubitemid 38813635)
6. B.D. Lowes Myocardial gene expression in dilated cardiomyopathy treated with beta-blocking agents N. Engl. J. Med. 346 2002 1357 1365 (Pubitemid 34754608)
7. J.M. Foody Beta-blocker therapy in heart failure: scientific review J. Am. Med. Assoc. 287 2002 883 889 (Pubitemid 34252037)
8. E. Braunwald Alterations in the activity of the adrenergic nervous system in heart failure UCLA Forum Med. Sci. 10 1970 289 294
9. P.E. Pool, and E. Braunwald Fundamental mechanisms in congestive heart failure Am. J. Cardiol. 22 1968 7 15
10. R.S. Kramer Augmented sympathetic neurotransmitter activity in the peripheral vascular bed of patients with congestive heart failure and cardiac norepinephrine depletion Circulation 38 1968 629 634
11. E. Braunwald, and C.A. Chidsey The adrenergic nervous system in the control of the normal of the normal and failing heart Proc. R. Soc. Med. 58 1965 1063 1066
12. F. Waagstein Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy Br. Heart J. 37 1975 1022 1036
13. F. Waagstein Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy: Metoprolol in Dilated Cardiomyopathy (MDC) Trial Study Group Lancet 342 1993 1441 1446 (Pubitemid 24000287)
14. M. Packer The effect of carvedilol on morbidity and mortality in patients with chronic heart failure: US Carvedilol Heart Failure Study Group N. Engl. J. Med. 334 1996 1349 1355 (Pubitemid 26152713)
15. W.S. Colucci Carvedilol inhibits clinical progression in patients with mild symptoms of heart failure: US Carvedilol Heart Failure Study Group Circulation 94 1996 2800 2806 (Pubitemid 26411744)
16. M.R. Bristow Effect of carvedilol on LV function and mortality in diabetic versus non-diabetic patients with ischemic or non-ischemic dilated cardiomyopathy Circulation 94 Suppl. 1 1996 644
17. A. Hjalmarson Effects of controlled-release metoprolol on total mortality, hospitalizations, and well being in patients with heart failure: The Metoprolol CR/XL Randomized Intervention Trial in Congestive Heart Failure (MERIT-HF) J. Am. Med. Assoc. 283 2000 1295 1302 (Pubitemid 30129796)
18. CIBIS II Investigators The Cardiac Insufficiency Bisoprolol Study II (CIBIS II): a randomized trial Lancet 353 1999 9 13
19. CIBIS Investigators and Committees A randomized trial of beta-blockade in heart failure: the Cardiac Insufficiency Bisoprolol Study (CIBIS) Circulation 90 1994 1765 1773
20. M. Packer Effect of carvedilol on the morbidity of patients with severe chronic heart failure: results of the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) Study Circulation 106 2002 2194 2199 (Pubitemid 35222212)
21. BEST Investigators A trial of the beta-blocker bucindolol in patients with advanced chronic heart failure N. Engl. J. Med. 344 2001 1659 1667
22. H.J. Dargie Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomized trial Lancet 357 2001 1385 1390 (Pubitemid 32455364)
23. P.A. Poole-Wilson Comparison of carvedilol and metoprolol on clinical outcomes in patients with heart failure in the Carvedilol or Metoprolol European Trial (COMET): randomized controlled trial Lancet 362 2003 7 13 (Pubitemid 36835815)
24. M.D. Flather Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS) Eur. Heart J. 26 2005 215 225 (Pubitemid 40222359)
25. R. Garg, and S. Yusuf Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials J. Am. Med. Assoc. 273 1995 1450 1456
26. R. Willenheimer Effects on survival and hospitalization of initiating treatment for chronic heart failure with bisoprolol followed by enalapril, as compared with the opposite sequence. Results of the randomized Cardiac Insufficiency Bisoprolol Study (CIBIS) III Circulation 112 2005 2426 2435 (Pubitemid 41504492)
27. Y.L. Sun Effect of beta-blockers on cardiac function and calcium handling protein in postinfarction heart failure rats Chest 128 2005 1812 1821
28. A. Di Lenarda Long-term effects of carvedilol in idiopathic dilated cardiomyopathy with persistent left ventricular dysfunction despite chronic metoprolol. The Heart-Muscle Disease Study Group J. Am. Coll. Cardiol. 33 1999 1926 1934
29. M. Metra Differential effects of beta-blockers in patients with heart failure: a prospective, randomized, double-blind comparison of the long-term effects of metoprolol versus carvedilol Circulation 102 2000 546 551 (Pubitemid 30642529)
30. J.E. Sanderson Beta-blockade in heart failure: a comparison of carvedilol with metoprolol JACC 34 1999 1522 1528 (Pubitemid 29528667)
31. S. Jacob Differential effect of chronic treatment with two beta-blocking agents on insulin sensitivity: the carvedilol-metoprolol study J. Hypertens. 14 1996 489 494 (Pubitemid 26161099)
32. T.L. Yue Carvedilol, a new vasodilator and beta adrenoceptor antagonist, is an antioxidant and free radical scavenger J. Pharmacol. Exp. Ther. 263 1992 92 98
33. R.L. Levy Transient tachycardia: prognostic significance alone and in association with transient hypertension J. Am. Med. Assoc. 129 1945 585 588
34. A. Dyer Heart rate as a prognostic factor for coronary heart disease and mortality findings in three Chicago epidemiological studies Am. J. Epidemiol. 112 1980 736 749 (Pubitemid 11130662)
35. A. Benetos Influence of heart rate on mortality in a French population: role of age, gender and blood pressure Hypertension 33 1999 44 52 (Pubitemid 29061840)
36. E. Kristal-Boneh The association of resting heart rate with cardiovascular, cancer and all-cause mortality. Eight year follow up of 3527 male Israeli employees (the CORDIS study) Eur. Heart J. 21 2000 116 124 (Pubitemid 30072626)
37. F. Seccarreccia Heart rate as a predictor of mortality. The Mattis Project Am. J. Public Health 91 2001 1258 1263
38. M.W. Gillmann Influence of heart rate on mortality among persons with hypertension: the Framingham Study Am. Heart J. 125 1993 1148 1154
39. K. Fox Heart rate as a prognostic risk factor in patients with coronary artery disease and left ventricular systolic dysfunction (BEATIFUL): a subgroup analysis of a randomized controlled trial Lancet 372 2008 817 821
40. J. Kjekshus, and L. Gullestad Heart rate as a therapeutic target in heart failure Eur. Heart J. Suppl. 1 Suppl. H 1999 H64 H69
41. A. Hjalmarson Heart rate: an independent risk factor in cardiovascular disease Eur. Heart J. Suppl. 9 Suppl. F 2007 F3 F7
42. P. Lechat Heart rate and cardiac rhythm relationships with bisoprolol benefit in chronic heart failure in CIBIS II Trial Circulation 103 2001 1428 1433 (Pubitemid 32220636)
43. F.A. McAlister Meta-analysis: beta-blocker dose, heart rate reduction, and death in patients with heart failure Ann. Intern. Med. 150 2009 784 794
44. K. Fox Ivabradine for patients with stable coronary artery disease and left ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial Lancet 372 2008 807 816
45. L. Gullestad What resting heart rate should one aim for when treating patients with heart failure with a beta-blocker? Experiences from the Metoprolol Controlled Release/Extended Release Randomized Intervention Trial in Chronic Heart Failure (MERIT-HF) J. Am. Coll. Cardiol. 45 2005 252 259 (Pubitemid 40094734)
46. K. Swedberg Ivabradine and outcomes in chronic heart failure (SHIFT): a randomized placebo-controlled study Lancet 376 2010 875 885
47. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology Eur. Heart J. 29 2008 2388 2442
48. J. Mariell 2009 Focused update: ACCF/AHA guidelines for the diagnosis and management of heart failure in adults J. Am. Coll. Cardiol. 53 2009 1343 1382